Javascript must be enabled to continue!
Nota de retractación
View through CrossRef
Retractación de: Análisis de las dificultades de los estudiantes angloparlantes con el aprendizaje del español en Jamaica. Perea Santos, L., y Valencia Mosquera, E. (Vol. 18 No. 34, 2018, pp. 189-200). doi: 10.22518/usergioa/jour/ccsh/2018.1/a13
Title: Nota de retractación
Description:
Retractación de: Análisis de las dificultades de los estudiantes angloparlantes con el aprendizaje del español en Jamaica.
Perea Santos, L.
, y Valencia Mosquera, E.
(Vol.
18 No.
34, 2018, pp.
189-200).
doi: 10.
22518/usergioa/jour/ccsh/2018.
1/a13.
Related Results
A Microdose Clinical Trial to Evaluate 64Cu-NOTA-Trastuzumab as a Positron Emission Tomography Imaging Agent in Patients with Breast Cancer
A Microdose Clinical Trial to Evaluate 64Cu-NOTA-Trastuzumab as a Positron Emission Tomography Imaging Agent in Patients with Breast Cancer
Abstract
Background: The purpose of this study was to evaluate the biodistribution and safety of 64Cu-1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA)-Trastuzumab, a nov...
A preliminary clinical trial to evaluate 64Cu-NOTA-Trastuzumab as a positron emission tomography imaging agent in patients with breast cancer
A preliminary clinical trial to evaluate 64Cu-NOTA-Trastuzumab as a positron emission tomography imaging agent in patients with breast cancer
Abstract
Background
The purpose of this study was to evaluate both the biodistribution and safety of 64Cu-1,4,7-triazacyclononane-1,4,7-triacetic ac...
A Preliminary Clinical Trial to Evaluate 64Cu-NOTA-Trastuzumab as a Positron Emission Tomography Imaging Agent in Patients with Breast Cancer
A Preliminary Clinical Trial to Evaluate 64Cu-NOTA-Trastuzumab as a Positron Emission Tomography Imaging Agent in Patients with Breast Cancer
Abstract
Background: The purpose of this study was to evaluate both the biodistribution and safety of 64Cu-1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA)-Trastuzumab, ...
A Preliminary Clinical Trial to Evaluate 64Cu-NOTA-Trastuzumab as a Positron Emission Tomography Imaging Agent in Patients with Breast Cancer
A Preliminary Clinical Trial to Evaluate 64Cu-NOTA-Trastuzumab as a Positron Emission Tomography Imaging Agent in Patients with Breast Cancer
Abstract
Background: The purpose of this study was to evaluate both the biodistribution and safety of 64Cu-1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA)-Trastuzumab, ...
Nota de Retractación
Nota de Retractación
Retractación de: Violencia política en Colombia. Paradojas e institucionalización de una disfunción. Ortiz Jiménez, W. (Vol. 12 No. 22, 2012, pp. 129-142)....
Nota de retractación
Nota de retractación
Retractación de: La calidad de la democracia. Examen de sus fundamentos conceptuales a comienzos del siglo XXI. Rojas-Betancur, M., Bocanument-Arbeláez, M., Gallego-Quiceno, D., y...
Nota de retractación
Nota de retractación
Retractación de: Neuroaprendizaje, una propuesta educativa: herramientas para mejorar la praxis del docente. Pherez, G., Vargas, S., y Jerez, J. (Vol. 18 No. 34, 2018, pp. 149-166...
Nota de retractación
Nota de retractación
Retractación de: Factores asociados a actitudes sobre la sexualidad en la vejez en Medellín, Colombia. Ramos Caballero, E., y Melguizo Herrera, E. (Vol. 17 No. 33, 2017, pp. 267-2...

